Tag: pharmaceuticals
-
Chip Device Tests for Cancer Drug Efficacy, Toxicity
A configurable chip device simulating several human organs is shown in lab tests to simultaneously test cancer drugs for both their efficacy and toxicity.
-
Sanofi, Alphabet Partner on A.I., Analytics
Drug maker Sanofi and Alphabet, the parent company of Google, are collaborating on the use of artificial intelligence and analytics for more personalized health care.
-
Topical Immune Drug Reverses Skin Disease
A drug targeting immune system enzymes used as a skin cream is shown in a clinical trial to reverse effects of vitiligo, or loss of skin coloring.
-
Foundation Supports Muscular Dystrophy RNA Therapy
A university spin-off company is receiving a foundation grant to advance its Crispr technology targeting RNA to treat a form of muscular dystrophy.
-
Antibiotics Synthesized from Scorpion Venom
Biochemistry labs in the U.S. and Mexico isolated and synthesized key compounds from scorpion venom that kills bacteria resistant to antibiotics.
-
DoD Funding Vaccine, Therapy Delivery Device
The U.S. Department of Defense is supporting creation of a small, portable device that safely sends vaccines and therapies through the skin.
-
Engineered Antibody Delays Type 1 Diabetes Onset
Results from a clinical trial show a synthetic antibody delayed for about 2 years the start of type 1 diabetes symptoms among people at high risk of the disease.
-
Repurposing an Anti-Inflammatory Drug to Treat a Life-Threatening Disease
Researchers successfully identified a common drug compound, a non-steroidal anti-inflammatory, that is active against all growing stages of the parasite that causes schistosomiasis.
-
Gut Microbe Links to Autism Revealed
Lab mice with bacteria transplanted from human intestines show signs that autism behaviors may result from the state of their gut microbes.
-
Strep A Vaccine Project Launched
An international initiative is underway to begin work on a vaccine against group A streptococcus infections becoming resistant to today’s antibiotics.